Factors associated with non-completion of follow-up: 33-month latent tuberculous infection treatment trial.

Moro RN, Sterling TR, Saukkonen J, Vernon A, Horsburgh CR, Chaisson RE, Hamilton CD, Villarino ME, Goldberg S
Int J Tuberc Lung Dis. 2017 21 (3): 286-296

PMID: 28087928 · PMCID: PMC6563818 · DOI:10.5588/ijtld.16.0469

MeSH Terms (16)

Adult Antitubercular Agents Directly Observed Therapy Female Follow-Up Studies Homeless Persons Humans Isoniazid Latent Tuberculosis Male Medication Adherence Multivariate Analysis Proportional Hazards Models Risk Factors Sex Factors Time Factors

Connections (1)

This publication is referenced by other Labnodes entities: